LIPELLA PHARMACEUTICALS INC (LIPO) Stock Analyst Earnings Estimates
NASDAQ:LIPO - Nasdaq - US53630L2097 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 259.35K -73.03% | 184.16K -28.99% | 449.62K 144.15% | 370.26K -17.65% | -100.00% | ||
| EBITDA YoY % growth | N/A | N/A | -4.744M | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.916M -3,268.79% | -2.59M -35.17% | -4.746M -83.26% | -5.598M -17.95% | -8.556M -52.84% | -12.834M -50.00% | |
| Operating Margin | -738.70% | -1,406.23% | -1,055.55% | -1,511.85% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -8.01 | -5.30 33.76% | -17.77 -235.00% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -2.48 |
| Revenue Q2Q % growth | N/A |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -1.896M -159.89% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.29 | -0.98 | -0.31 | -31.74% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 136.43K 27.89% | % | ||
| Q1 2024 Q2Q % growth | 145.88K 23.57% | % | ||
| Q4 2023 Q2Q % growth | 120.84K -19.98% | % | ||
| Q3 2023 Q2Q % growth | 104.05K 213.88% | % | ||
| Q4 2022 Q2Q % growth | 151.01K 483.50% | % | ||
| Q3 2022 Q2Q % growth | 33.15K -85.80% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -700% | 0% | -1327.27% |
| Revenue | N/A | N/A | 0% | 28.72% |